Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Ablynx initiates Phase IIb anti-RSV nanobody trial for infants

europeanpharmaceuticalreviewJanuary 13, 2017

Tag: Ablynx , infants

PharmaSources Customer Service